Re: Delivery of inhaled aerosolized prostacyclin (IAP)
P V
PV
van Heerden
B M
BM
Power
R C
RC
Leonard
D000280:Administration, Inhalation; D000336:Aerosols; D002021:Buffers; D011464:Epoprostenol / Q000008:administration & dosage / Q000627:therapeutic use*; D004867:Equipment Design; D005998:Glycine; D006801:Humans; D006976:Hypertension, Pulmonary / Q000188:drug therapy; D000860:Hypoxia / Q000188:drug therapy; D008168:Lung / Q000098:blood supply*; D009330:Nebulizers and Vaporizers; D010316:Particle Size; D014677:Pharmaceutical Vehicles; D012128:Respiratory Distress Syndrome / Q000188:drug therapy; D012965:Sodium Chloride; D014665:Vasodilator Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D014783:Viscosity
D000336:Aerosols; D002021:Buffers; D014677:Pharmaceutical Vehicles; D014665:Vasodilator Agents; D012965:Sodium Chloride; D011464:Epoprostenol; D005998:Glycine